Lv62
2139 积分 2022-03-04 加入
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
1个月前
已完结
Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIB trial
1个月前
已完结
Common misconceptions of randomized controlled trials in oncology
3个月前
已完结
Causal machine learning for predicting treatment outcomes
5个月前
已完结
The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression
8个月前
已完结
Tumor budding as a prognostic marker in stage-III rectal carcinoma
8个月前
已完结
Tumor budding as a prognostic indicator in colorectal carcinoma: a retrospective study of primary colorectal carcinoma cases in a tertiary care center
8个月前
已完结
Insights into the Loop at the E-Selectin Binding Site: From Open to Close Conformation
8个月前
已完结
Simulation of the ligand-leaving process of the human heat shock protein
8个月前
已完结
Molecular mechanism of methyl-dependent and spatial-specific DNA recognition of c-Jun homodimer
8个月前
已完结
皖公网安备34019202002308
